Cancer Research · 2017 · 92 citations · 13 references
Abstract Cancer sequencing studies are increasingly comprehensive and well powered, returning long lists of somatic mutations that can be difficult to sort and interpret. Diligent analysis and quality control can require multiple computational tools of distinct utility and producing disparate output, creating additional challenges for the investigator. The Cancer-Related Analysis of Variants Toolkit (CRAVAT) is an evolving suite of informatics tools for mutation interpretation that includes mutation mapping and quality control, impact prediction and extensive annotation, gene- and mutation-level interpretation, including joint prioritization of all nonsilent mutation consequence types, and structural and mechanistic visualization. Results from CRAVAT submissions are explored in an interactive, user-friendly web environment with dynamic filtering and sorting designed to highlight the most informative mutations, even in the context of very large studies. CRAVAT can be run on a public web portal, in the cloud, or downloaded for local use, and is easily integrated with other methods for cancer omics analysis. Cancer Res; 77(21); e35–38. ©2017 AACR.
13
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek, Konrad J. Karczewski, Eric Vallabh Minikel et al. · Nature · 2016 · 10.1K citations · Full text
Phenotypic Variation, Protein-coding Genetic Variation, Genetics +5
An integrated map of genetic variation from 1,092 human genomes
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon Forbes, David Beare, Prasad Gunasekaran et al. · Nucleic Acids Research · 2014 · 2.4K citations · Full text
Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants
Wenqing Fu, Timothy D. O’Connor, Goo Jun et al. · Nature · 2012 · 1K citations · Full text